Pathological gambling and substance use disorders

American Journal of Drug and Alcohol Abuse

Volumn 36, Issue 5, 2010, Pages 242-247

  Wareham, Justin D ^a   Potenza, Marc N ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; Gambling; Impulsivity; Pathological gambling; Substance dependence; Substance use disorder

Indexed keywords

ACETYLCYSTEINE; AMFEBUTAMONE; FLUVOXAMINE; HALOPERIDOL; LITHIUM; OPIATE ANTAGONIST; OPIATE RECEPTOR; PAROXETINE; PLACEBO; SERTRALINE;

ALCOHOLISM; BEHAVIOR DISORDER; CEREBROSPINAL FLUID; CINGULATE GYRUS; CLINICAL TRIAL; COCAINE DEPENDENCE; COMORBIDITY; CORPUS STRIATUM; DRUG DEPENDENCE; DRUG EFFICACY; DRUG TOLERABILITY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MOTIVATION; PATHOLOGICAL GAMBLING; REVIEW; SUBSTANCE ABUSE; TOBACCO DEPENDENCE;

COMORBIDITY; GAMBLING; HUMANS; MALE; NEUROTRANSMITTER AGENTS; SUBSTANCE-RELATED DISORDERS;

EID: 77956307386     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952991003721118     Document Type: Review

References (60)

1. American Psychiatric Association Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders (4th Ed. - Text Revision). Washington, DC: American Psychiatric Association, 2000.
2. Potenza MN. Should addictive disorders include non-substance-related conditions? Addiction 2006; 101:142-151.
3. Brewer JA, Potenza MN. The neurobiology and genetics of impulse control disorders: Relationships to drug addictions. Biochem Pharmacology 2008; 75:63-75.
4. Verdejo-Garcia A, Lawrence AJ, Clark L. Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev 2008; 32:777-810.
5. Petry NM, Stinson FS, Grant BF. Co-morbidity of DSM-IV pathological gambling and other psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2005; 66:564-574.
6. Kessler RC, Hwang I, LaBrie R, Petukhova M, Sampson NA, Winters KC, Shaffer HJ. DSM-IV pathological gambling in the National Comorbidity Survey Replication. Psychological Med 2008; 38:1351-1360.
7. Cunningham-Williams RM, Cottler LB, Compton WM, Spitznagel EL. Taking chances: Problem gamblers and mental health disorders-Results from the St. Louis Epidemiologic Catchment Area Study. Am J Public Health 1998; 88:1093-1096.
8. Desai RA, Potenza MN. Gender differences in the associations between problem gambling and psychiatric disorders. Soc Psychol Psychiatr Epi 2008; 43:173-183.
9. Toce-Gerstein M, Gerstein DR, Volberg RA. A hierarchy of gambling disorders in the community. Addiction 2003; 98:1661-1672.
10. Grant J, Levine L, Kim D, Potenza M.N. Impulse control disorders in adult psychiatric inpatients. Am J Psychiatry 2005, 162, 2184-2188.
11. Grant JE, Williams KA, Potenza MN. Impulse control disorders in adolescent inpatients: Co-occurring disorders and sex differences. J Clin Psychiatry 2007; 68:1584-1591.
12. Strong DR, Kahler CW. Evaluation of the continuum of gambling problems using the DSM-IV. Addiction 2007; 102:713-721.
13. Brewer JA, Grant JE, Potenza MN. The treatment of pathologic gambling. Addict Disorders Treatment 2008; 7:1-14.
14. Pallesen S, MoldeH,Arnestad HM, Laberg JC, Skutle A, Iversen E, Stoylen IJ, Kvale G, Holsten F. Outcome of pharmacological treatments of pathological gambling: A review and meta-analysis. J Clin Psychopharmacol 2007; 27:357-364.
15. Kim SW, Grant JE, Adson DE, Shin YC, Zaninelli R. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry 2002; 63: 501-507.
16. Grant JE, Kim SW, Potenza MN, Blanco C, Ibanez A, Stevens L, Hektner JM, Zaninelli R. Paroxetine treatment of pathological gambling: A multicentre randomized controlled trial. International Clinical Psychopharmacology 2003; 18:243-249.
17. Saiz-Ruiz J, Blanco C, Ibanez A, Masramon X, Gomez MM, Madrigal M, Diez T. Sertraline treatment of pathological gambling: a pilot study. J Clin Psychiatry 2005; 66:28-33.
18. Hollander E,DeCaria CM, Finkell JN, Begaz T,Wong CM, Cartwright C.A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling. Biological Psychiatry 2000; 47:813-817.
19. Hollander E, Pallanti S, Allen A, Sood E, Baldini Rossi N. Does sustainedrelease lithium reduce impulsive gambling and affective instability versusplacebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry 2005; 162:137-145.
20. Grant JE, Kim SW, Odlaug BL. N-Acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry 2007; 62:652-657.
21. Grant JE, Odlaug BL, Potenza MN, Hollander E, Kim SW. Lowdose nalmefene for pathological gambling: A multi-center, double-blind, placebo-controlled trial. American College of Neuropsychopharmacology 48th Annual Meeting, Hollywood, FL, 2009.
22. Grant JE, Potenza MN, Hollander E, Cunningham-Williams R, Nurminen T, Smits G, Kallio A. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry 2006; 163:303-312.
23. Kim SW, Grant JE, Adson DE, Shin YC. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biological Psychiatry 2001; 49:914-921.
24. Grant JE, Kim SW, Hartman BK. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry 2008; 69:783-789.
25. Grant JE, Kim SW, Hollander E, Potenza MN. Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacol 2008; 200:521-527.
26. PetryNM, Alessi SM,Carroll KM,Hanson T,MacKinnon S, Rounsaville B, Sierra S. Cognitive-behavioral therapy for pathological gamblers. J Consult Clin Psychology 2006; 74:555-567.
27. Gooding P, Tarrier N. A systematic review and meta-analysis of cognitivebehavioural interventions to reduce problem gambling: hedging our bets? Behav Res Ther 2009; 47:592-607.
28. Sylvain C, Ladouceur R, Boisvert J-M. Cognitive and behavioral treatment of pathological gambling: A controlled study. Journal of Consulting and Clinical Psychology 1997; 65:727-732.
29. Ladouceur R, Sylvain C, Boutin C, Lachance S, Doucet C, Leblond J, Jacques C. Cognitive treatment of pathological gambling. J Nerv Ment Dis 2001; 189:774-780.
30. Petry NM, Weinstock J, Morasco BJ, Ledgerwood DM. Brief motivational interventions for college student problem gamblers. Addiction 2009; 104:1569-1578.
31. Hodgins DC, Currie SR, Currie G, Fick GH. Randomized trial of brief motivational treatments for pathological gamblers: More is not necessarily better. J Consult Clin Psychol 2009; 77:950-960.
32. Petry NM. Gamblers Anonymous and cognitive-behavioral therapies for pathological gamblers. J Gambling Stud 2005; 21:27-33.
33. Slutske WS. Natural recovery and treatment-seeking in pathological gambling: results of two national surveys. Am J Psychiatry 2006; 163:297-302.
34. Tamminga CA, Nestler EJ. Pathological gambling: Focusing on the addiction, not the activity. Am J Psychiatry 2006; 163:180-181.
35. Potenza MN, Steinberg MA, McLaughlin SD, Wu R, Rounsaville BJ, OMalley SS. Gender-related differences in the characteristics of problem gamblers using a gambling helpline.AmJ Psychiatry 2001; 158:1500-1505.
36. Tavares H, Zilberman ML, Beites FJ, Gentil V. Gender differences in gambling progression. J Gambling Stud 2001, 17, 151-160.
37. Potenza MN. The neurobiology of pathological gambling and drug addiction: An overview and new findings. Phil. Trans. R. Soc. B 2008; 363:3181-3189.
38. Zack M, Belsito L, Scher R, Eissenberg T, Corrigall WA. Effects of abstinence and smoking on information processing in adolescent smokers. Psychopharmacology 2001; 153:249-257.
39. Potenza MN,Voon V,WeintraubD.Drug Insight: impulse control disorders and dopamine therapies in Parkinsons disease. Nat Clin Pract Neuro 2007; 3:664-672.
40. Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, Moberg PJ, Stern MB. Dopamine agonist use is associated with impulse control disorders in Parkinsons disease. Arch Neurol 2006; 63:969-973.
41. Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy MA, Voon V, Whetteckey J, Wunderlich GR, Lang AE. Dopaminergic therapy and other clinical factors associated with impulse control disorders in Parkinsons disease: A cross-sectional study of 3,090 patients. Arch Neurol. In press.
42. Voon V, Hassan K, ZurowskiM, Duff-Canning S, de SouzaM, Fox S, Lang AE, Miyasaki J. Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology 2006; 66:1750-1752.
43. Reuter J, Raedler T, Rose M, Hand I, Glascher J, Buchel C. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 2005; 8:147-148.
44. Potenza MN, Steinberg MA, Skudlarski P, Fulbright RK, Lacadie CM, Wilber MK, Rounsaville BJ, Gore JC, Wexler BE. Gambling urges in pathological gambling: A functional magnetic resonance imaging study. Arch Gen Psychiatry 2003; 60:828-836.
45. Potenza MN, Leung HC,Blumberg HP, PetersonBS, Fulbright RK, Lacadie CM, Skudlarski P, Gore JC. An FMRI Stroop task study of ventromedial prefrontal cortical function in pathological gamblers. Am J Psychiatry 2003; 160:1990-1994.
46. Cavedini P, Riboldi G, Keller R, DAnnucci A, Bellodi L. Frontal lobe dysfunction in pathological gambling patients. Biological Psychiatry 2002; 51:334-341.
47. Tanabe J, Thompson L, Claus E,Dalwani M, Hutchison K, Banich MT. Prefrontal cortex activity is reduced in gambling and nongambling substance users during decision-making. Hum Brain Mapp 2007; 28:1276-1286.
48. Weintraub D. Emergence of problematic addiction-relevant behaviors in Parkinsons patients on dopamine replacement therapy. College of Problems of Drug Dependence Conference, Boca Raton, FL, June, 2008.
49. Potenza MN. Neurobiologies of Pathological Gambling and Drug Addictions. American College of Neuropsychopharmacology, Hollywood, FL, Dec 10, 2009.
50. de Ruiter MB, Veltman DJ, Goudriaan AE, Oosterlaan J, Sjoerds Z, Van Den Brink W. Response perseveration and ventral prefrontal sensitivity to reward and punishment in male problem gamblers and smokers. Neuropsychpharmacol 2009; 34:1027-1038.
51. Goudriaan AE, Oosterlaan J, de Beurs E, Van Den Brink W. Pathological gambling: A comprehensive review of biobehavioral findings. Neurosci Biobehav Rev 2004; 28:123-141.
52. Goudriaan AE, Oosterlaan J, de Beurs E, Van Den Brink W. Neurocognitive functions in pathological gambling: A comparison with alcohol dependence, Tourette syndrome and normal controls. Addiction 2006; 101:534-547.
53. Lawrence AJ, Luty J, Bogdan NA, Sahakian BJ, Clark L. Problem gamblers share deficits in impulsive decision-making with alcohol dependent individuals. Addiction 2009; 104:1006-1015.
54. Toneatto T. Cognitive psychopathology of problem gambling. Subst Use Misuse 1999; 34:1593-1604.
55. Steeves TDL,Miyasaki J, ZurowskiM, LangAE, Pellecchia G, van Eimeren T, Rusjan P, Houle S, Strafella AP. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: A [11C] raclopride PET study. Brain 2009; 132:1376-1385.
56. Shah KR, Eisen SA, Xian H, Potenza MN. Genetic studies of pathological gambling: A review of methodology and analyses of data from the Vietnam Era Twin (VET) Registry. J Gambling Stud 2005; 21:177-201.
57. Potenza MN, Xian H, Shah K, Scherrer JF, Eisen SA. Shared genetic contributions to pathological gambling and major depression in men. Arch Gen Psychiatry 2005; 62:1015-1021.
58. Potenza MN, Koran LM, Pallanti S. The relationship between impulse control disorders and obsessive-compulsive disorder: A current understanding and future research directions. Psychiatry Res 2009; 170:22-31.
59. Potenza MN. Impulsivity and compulsivity in pathological gambling and obsessive-compulsive disorder. Rev Brasileria de Psiquiatria 2007; 29:105-106.
60. Tavares H, Gentil V. Pathological gambling and obsessive compulsive disorder: Towards a spectrum of disorders of volition. Rev Bras Psiquiatr 2007; 29:107-117